A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

Tony Reiman; Kerry J. Savage; Michael Crump; Matthew C. Cheung; David MacDonald; Rena Buckstein; Stephen Couban; Eugenia Piliotis; Kevin Imrie; David Spaner; Sudeep Shivakumar; John Kuruvilla; Diego Villa; Lois E. Shepherd; Tanya Skamene; Chad Winch; Bingshu E. Chen; Annette E. Hay

doi:10.1080/10428194.2018.1515937

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

Tony Reiman, Kerry J. Savage, Michael Crump, Matthew C. Cheung, David MacDonald, Rena Buckstein, Stephen Couban, Eugenia Piliotis, Kevin Imrie, David Spaner, Sudeep Shivakumar, John Kuruvilla, Diego Villa, Lois E. Shepherd, Tanya Skamene, Chad Winch, Bingshu E. Chen, Annette E. Hay

科研成果: 期刊稿件 › 文章 › 同行评审

21 引用（Scopus）

源语言	英语
页（从-至）	912-919
页数	8
期刊	Leukemia and Lymphoma
卷	60
期	4
DOI	https://doi.org/10.1080/10428194.2018.1515937
出版状态	已出版 - 3月 21 2019
已对外发布	是

!!!ASJC Scopus Subject Areas

血液学
肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1080/10428194.2018.1515937

其它文件与链接

引用此

Reiman, T., Savage, K. J., Crump, M., Cheung, M. C., MacDonald, D., Buckstein, R., Couban, S., Piliotis, E., Imrie, K., Spaner, D., Shivakumar, S., Kuruvilla, J., Villa, D., Shepherd, L. E., Skamene, T., Winch, C., Chen, B. E., & Hay, A. E. (2019). A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. Leukemia and Lymphoma, 60(4), 912-919. https://doi.org/10.1080/10428194.2018.1515937

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. / Reiman, Tony; Savage, Kerry J.; Crump, Michael 等.
在: Leukemia and Lymphoma, 卷 60, 号码 4, 21.03.2019, 页码 912-919.

科研成果: 期刊稿件 › 文章 › 同行评审

Reiman, T, Savage, KJ, Crump, M, Cheung, MC, MacDonald, D, Buckstein, R, Couban, S, Piliotis, E, Imrie, K, Spaner, D, Shivakumar, S, Kuruvilla, J, Villa, D, Shepherd, LE, Skamene, T, Winch, C, Chen, BE & Hay, AE 2019, 'A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†', Leukemia and Lymphoma, 卷 60, 号码 4, 页码 912-919. https://doi.org/10.1080/10428194.2018.1515937

Reiman T, Savage KJ, Crump M, Cheung MC, MacDonald D, Buckstein R 等. A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†. Leukemia and Lymphoma. 2019 3月 21;60(4):912-919. doi: 10.1080/10428194.2018.1515937

@article{53441e54501b44a39c78d4b305b3db2c,

title = "A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†",

keywords = "Non-Hodgkin lymphoma, combination therapy, phase I trial, romidepsin",

author = "Tony Reiman and Savage, {Kerry J.} and Michael Crump and Cheung, {Matthew C.} and David MacDonald and Rena Buckstein and Stephen Couban and Eugenia Piliotis and Kevin Imrie and David Spaner and Sudeep Shivakumar and John Kuruvilla and Diego Villa and Shepherd, {Lois E.} and Tanya Skamene and Chad Winch and Chen, {Bingshu E.} and Hay, {Annette E.}",

note = "Publisher Copyright: {\textcopyright} 2018, {\textcopyright} 2018 Informa UK Limited, trading as Taylor & Francis Group.",

year = "2019",

month = mar,

day = "21",

doi = "10.1080/10428194.2018.1515937",

language = "English",

volume = "60",

pages = "912--919",

journal = "Leukemia and Lymphoma",

issn = "1042-8194",

publisher = "Informa Healthcare",

number = "4",

}

TY - JOUR

T1 - A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

AU - Reiman, Tony

AU - Savage, Kerry J.

AU - Crump, Michael

AU - Cheung, Matthew C.

AU - MacDonald, David

AU - Buckstein, Rena

AU - Couban, Stephen

AU - Piliotis, Eugenia

AU - Imrie, Kevin

AU - Spaner, David

AU - Shivakumar, Sudeep

AU - Kuruvilla, John

AU - Villa, Diego

AU - Shepherd, Lois E.

AU - Skamene, Tanya

AU - Winch, Chad

AU - Chen, Bingshu E.

AU - Hay, Annette E.

PY - 2019/3/21

Y1 - 2019/3/21

KW - Non-Hodgkin lymphoma

KW - combination therapy

KW - phase I trial

KW - romidepsin

UR - http://www.scopus.com/inward/record.url?scp=85054680037&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85054680037&partnerID=8YFLogxK

U2 - 10.1080/10428194.2018.1515937

DO - 10.1080/10428194.2018.1515937

M3 - Article

C2 - 30301414

AN - SCOPUS:85054680037

SN - 1042-8194

VL - 60

SP - 912

EP - 919

JO - Leukemia and Lymphoma

JF - Leukemia and Lymphoma

IS - 4

ER -

A phase I study of romidepsin, gemcitabine, dexamethasone and cisplatin combination therapy in the treatment of peripheral T-cell and diffuse large B-cell lymphoma; the Canadian cancer trials group LY.15 study†

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此